PRESS RELEASE
12 August 2026

IAM Strategy 300 Names Five Smart & Biggar Practitioners As Leading IP Strategists For 2026

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
Five intellectual property strategists from a leading law firm have been recognized in IAM Strategy 300 for their innovative approaches to creating and implementing strategies that maximize the value of IP portfolios. The honorees span diverse specializat
Canada

Congratulations to Stephen Beney, Charles Boulakia, Daphne Lainson, Daphne Maravei and David St-Martin for their inclusion in the 2026 edition of IAM Strategy 300: The World’s Leading IP Strategists. Each year, IAM Strategy 300 recognizes those who innovatively create and action strategies which realize and amplify the worth of IP portfolios.

Stephen Beney works with clients to assess IP needs and has helped secure patents for a wide range of innovators, including start-ups, small‑ to mid‑sized enterprises, major multinational companies and university researchers.

Charles Boulakia provides patent prosecution and portfolio management services in Canada and internationally, and advises clients on IP due diligence, validity and freedom‑to‑operate matters.

Daphne Lainson provides strategic advice and counselling to clients across the life cycle of a drug, including during pre-clinical and clinical development through to marketing and loss of exclusivity.

Daphne Maravei's practice focuses on the acquisition, clearance, prosecution, litigation and licensing of trademarks, patents, industrial designs and copyright. Daphne also counsels clients on portfolio management and filing strategies.

David St-Martin helps his clients in preparing patentability, validity, freedom-to-operate and infringement opinions concerning patents and guidance on patent portfolio management.

View the full 2026 list of IAM Strategy 300: The World’s Leading IP Strategists online.

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More